Floatz logo

ONC 206

Teratoid Rhabdoid Tumor

Jazz PharmaceuticalsSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Teratoid Rhabdoid Tumor cohort.

Asset / SponsorPhaseRating
Tazemetostat
Epizyme, Inc.
Phase 2B
ETOPOSIDE
Medical University of Vienna
Phase 2CCC
Cytosin-Arabinosid
Medical University of Vienna
Phase 2CCC
Thalidomide
Medical University of Vienna
Phase 2CCC
Dfn-15
Medical University of Vienna
Phase 2CCC

View all 39 →

Same molecule, other indications

ONC 206 is also rated in:

grade II meningiomaDormant
CC
Indicative ·
43 / 100
View asset →
ependymomaDormant
CC
Indicative ·
43 / 100
View asset →
central nervous system cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →